We analyzed bone marrow specimens obtained from 22 newly diagnosed AML patients for the presence of FLT3-ITD gene mutation, blast cell count, CD34, Bcl-xL, cyclin D1 and hENT1 expressions. Here, BCL2L1 is linked to acute myeloid leukemia.